EUVIMEDEUVIMED entdecken
Übersichtsarbeit

ARID1A mutations in cancer development: mechanism and therapy

Xuewei Zhang, Yixuan Zhang, Jinyi Zhao, Yinjie Wu, Na Zhang, Wenjing Shen iD

Carcinogenesis · 27.05.2023 · 44 (3) · 197-208

DOI: 10.1093/carcin/bgad011 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Carcinogenesis, online erschienen am 06.03.2023. Verfasst von Xuewei Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The First Hospital of China Medical University, Shenyang, 110001, China. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 163 Literaturangaben. Gefördert von: Department of Science and Technology of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AT-Rich Interaction Domain 1A (ARID1A) is an important SWItch/Sucrose Non-Fermentation (SWI/SNF) chromatin remodeling complex subunit, and its coding gene has a high mutation frequency in many cancers. Current studies have reported that ARID1A mutational status is correlated to cancer development, including cell proliferation, invasiveness, metastasis, and morphological alterations. ARID1A acts as a tumor suppressor, regulating gene transcription, participating in DNA damage response, and influencing tumor immune microenvironment and signaling pathways. The absence of ARID1A in cancer can lead to widespread dysregulation of gene expression in cancer initiation, promotion, and progression. For patients with ARID1A mutations, effective individualized treatment can improve the prognosis of patients. In this review, we aim to discuss the mechanism of ARID1A mutations in cancer development and explore the significance of discoveries for treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA-Binding ProteinsNeoplasmsHumansNuclear ProteinsTranscription FactorsMutationTumor Microenvironment

Substanzen

DNA-Binding ProteinsNuclear ProteinsTranscription FactorsARID1A protein, human

Autor:innen und Institutionen

  • Department of Gynecology, The First Hospital of China Medical University, Shenyang, 110001, China.
  • Department of Hepatobiliary Surgery, The First Hospital of China Medical University, Shenyang, 110001, China.

ORCID-Profile: Wenjing Shen

Förderung

  • Department of Science and Technology of Liaoning Province

Zitieren

APA

Zhang, X., Zhang, Y., Zhao, J., Wu, Y., Zhang, N., & Shen, W. (2023). ARID1A mutations in cancer development: mechanism and therapy. Carcinogenesis, 44(3), 197-208. https://doi.org/10.1093/carcin/bgad011

Vancouver

Zhang X, Zhang Y, Zhao J, Wu Y, Zhang N, Shen W. ARID1A mutations in cancer development: mechanism and therapy. Carcinogenesis. 2023;44(3):197-208. doi:10.1093/carcin/bgad011

BibTeX
@article{Zhang2023,
  author = {Zhang, Xuewei and Zhang, Yixuan and Zhao, Jinyi and Wu, Yinjie and Zhang, Na and Shen, Wenjing},
  title = {ARID1A mutations in cancer development: mechanism and therapy},
  journal = {Carcinogenesis},
  year = {2023},
  volume = {44},
  number = {3},
  pages = {197--208},
  doi = {10.1093/carcin/bgad011}
}
Kostenlos starten →